TickerStat.comwe like data

Inhibitor Therapeutics, Inc. (INTI)

Price$0.07405Cached quote
INTIOTC
Loading local price history

Financial charts

Revenue

Net income

Free cash flow

No reported data

Total cash / debt

CashTotal debt

Financial statements

14 annual periodsNewest to oldest
20252024202320222021202020192018201720162015201420132012
Revenue$0$0$0$0$0$0$0$0$0$0$0$0$0—
Research & development$1.7M$1.8M$1.4M$6,150$4,905$185,294$1.2M$2.6M$2.2M$2.6M$1.7M$2.4M$1.1M—
Operating expenses$3.4M$3.7M$3.4M$657,926$325,395$1.1M$2.7M$4.6M$5.1M$7.0M$3.9M$3.9M$2.0M$560,670
Operating income−$3.4M−$3.7M−$3.4M−$657,926−$325,395−$1.1M−$2.7M−$4.6M−$5.1M−$7.0M−$3.9M−$3.9M−$2.0M−$560,670
EBITDA−$3.4M−$3.7M−$3.4M$12.2M————————−$2.0M−$560,670
Net income−$3.3M−$3.3M−$3.0M$12.1M−$298,632−$1.1M−$2.7M−$4.6M−$5.1M−$7.0M−$3.9M−$4.0M−$1.8M$186,366
Basic EPSper basic share-$0.02-$0.02-$0.02$0.03$0.00$0.00-$0.01-$0.01-$0.01-$0.02-$0.02-$0.04-$0.10$0.01
Diluted EPSper diluted share-$0.02-$0.02-$0.02$0.03$0.00$0.00-$0.01-$0.01-$0.01-$0.02-$0.02-$0.04-$0.10$0.01
Review official source filings ↗

Owners

Reported shareholders

Reference date Jun 30, 2026

Reported holdings Number of shares

View holders
Top 6 reported holders of INTI
HolderShares held
OSMAN RONALD E / Ronald E Osman Irrevocable Trust III
23.55M
MCNULTY JAMES A
1.95M
SEARS SAMUEL P JR
1.28M
Yanez Michelle
896.27K
Vasisht Niraj
200K
Jerman Michael Allen
180.41K

Bars compare reported share counts. A matching total for this share class and reporting period is unavailable, so percentages are not shown.

Source: SEC Form 4 ↗Updated Sep 29, 2026 · Quarterly data

Insider buys & sells

Jul 1, 2024–Jun 30, 2026
Buys0$0.00 disclosed value
Sells (SEC code S)0$0.00 disclosed value
0 recent transactions
No insider transactions transactions were reported in the stored SEC coverage.
Review ownership filings at SEC.gov ↗

Community posts

View community

It’s quiet here.

No posts about INTI yet. Start the conversation.

Write the first post